Kumar S Abhishek, Alisha Aggarwal, Vibhor Tak, Vidhi Jain, Sarika P Kombade
{"title":"The rise of Extended spectrum β-lactamase (ESBL) producing ceftriaxone resistant Salmonella Typhi from western Rajasthan, India.","authors":"Kumar S Abhishek, Alisha Aggarwal, Vibhor Tak, Vidhi Jain, Sarika P Kombade","doi":"10.2174/0118715265382823250818113104","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Typhoid fever, caused by Salmonella Typhi and Paratyphi, remains a sig-nificant public health concern, particularly in developing countries. The emergence of antimicrobial resistance, including resistance to first-line drugs, fluoroquinolones, and the development of re-sistance to ceftriaxone, poses a significant threat to effective treatment.</p><p><strong>Methods: </strong>This study investigated extended-spectrum β-lactamase (ESBL)-producing Salmonella Typhi isolates from blood samples of patients with suspected typhoid fever at a tertiary care hospital in Western Rajasthan, India, between April 2022 and May 2024. Antimicrobial susceptibility testing followed by PCR for ESBL-producing genes (blaTEM, blaSHV, blaCTX-M) and blaCTX-M sub-types (blaCTX-M1, blaCTX-M2, blaCTX-M8, blaCTX-M9, blaCTX-M10, blaCTX-M14, and blaCTX-M15) was performed.</p><p><strong>Results: </strong>Among 79 Salmonella Typhi isolates, 18 (22.8%) exhibited resistance to ceftriaxone. PCR analysis revealed blaCTX-M as the predominant ESBL gene, detected in 77.8% of resistant isolates. Notably, blaCTX-M1, blaCTX-M15, and blaCTX-M10 types were identified among the blaCTX-M-positive isolates.</p><p><strong>Discussion: </strong>In our study, 48% of Salmonella Typhi strains were resistant to fluoroquinolones, while chloramphenicol and co-trimoxazole showed re-emerging susceptibility (87%), likely due to their restricted use. Emerging ceftriaxone resistance, mediated by ESBL genes, predominantly blaCTX-M (especially blaCTX-M-15 and blaCTX-M-1) and blaSHV, poses challenges in clinical management. Notably, our study detected blaCTX-M10, which has not been previously reported in S. Typhi. Re-sistance gene spread is attributed to plasmids prevalent in E. coli and Klebsiella, which facilitate horizontal transfer. Study limitations include a small sample size, the absence of whole-genome sequencing, and a lack of clinical outcome data.</p><p><strong>Conclusion: </strong>This study highlights the emergence of ceftriaxone-resistant Salmonella Typhi in Western Rajasthan, India. The high prevalence of blaCTX-M-producing isolates underscores the importance of ongoing surveillance and the implementation of infection control measures to prevent the further spread of antimicrobial resistance. Additionally, this study also highlights the re-emergence of sensitivity to chloramphenicol and co-trimoxazole.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118715265382823250818113104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Typhoid fever, caused by Salmonella Typhi and Paratyphi, remains a sig-nificant public health concern, particularly in developing countries. The emergence of antimicrobial resistance, including resistance to first-line drugs, fluoroquinolones, and the development of re-sistance to ceftriaxone, poses a significant threat to effective treatment.
Methods: This study investigated extended-spectrum β-lactamase (ESBL)-producing Salmonella Typhi isolates from blood samples of patients with suspected typhoid fever at a tertiary care hospital in Western Rajasthan, India, between April 2022 and May 2024. Antimicrobial susceptibility testing followed by PCR for ESBL-producing genes (blaTEM, blaSHV, blaCTX-M) and blaCTX-M sub-types (blaCTX-M1, blaCTX-M2, blaCTX-M8, blaCTX-M9, blaCTX-M10, blaCTX-M14, and blaCTX-M15) was performed.
Results: Among 79 Salmonella Typhi isolates, 18 (22.8%) exhibited resistance to ceftriaxone. PCR analysis revealed blaCTX-M as the predominant ESBL gene, detected in 77.8% of resistant isolates. Notably, blaCTX-M1, blaCTX-M15, and blaCTX-M10 types were identified among the blaCTX-M-positive isolates.
Discussion: In our study, 48% of Salmonella Typhi strains were resistant to fluoroquinolones, while chloramphenicol and co-trimoxazole showed re-emerging susceptibility (87%), likely due to their restricted use. Emerging ceftriaxone resistance, mediated by ESBL genes, predominantly blaCTX-M (especially blaCTX-M-15 and blaCTX-M-1) and blaSHV, poses challenges in clinical management. Notably, our study detected blaCTX-M10, which has not been previously reported in S. Typhi. Re-sistance gene spread is attributed to plasmids prevalent in E. coli and Klebsiella, which facilitate horizontal transfer. Study limitations include a small sample size, the absence of whole-genome sequencing, and a lack of clinical outcome data.
Conclusion: This study highlights the emergence of ceftriaxone-resistant Salmonella Typhi in Western Rajasthan, India. The high prevalence of blaCTX-M-producing isolates underscores the importance of ongoing surveillance and the implementation of infection control measures to prevent the further spread of antimicrobial resistance. Additionally, this study also highlights the re-emergence of sensitivity to chloramphenicol and co-trimoxazole.